4Q5-20370-23885
4 vaccinations
1 coded response
13 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 284 / NC
- Registered
- 2022-12-29
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-02
Dose 1 — Pfizer-BioNTech
-
2021-01-29
Dose 2 — Pfizer-BioNTech
-
2021-10-20
Dose 3 — Pfizer-BioNTech
-
2022-12-29
Registered in v-safe
-
2022-12-29
Dose 4 — Pfizer-BioNTech
-
2022-12-29
Survey response — day 0, dose 4MedDRA: Pregnancy — Feeling: GoodFree text: Currently 12 weeks pregnantMedDRA releases: 2024-11 · check-in free text available
-
2022-12-30
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2022-12-31
- 2023-01-02
- 2023-01-03
- 2023-01-04
- 2023-01-05
- 2023-01-14
- 2023-01-21
- 2023-02-04
- 2023-02-09
- 2023-03-30
- 2023-06-29
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-02 | Pfizer-BioNTech | No |
| 2 | 2021-01-29 | Pfizer-BioNTech | No |
| 3 | 2021-10-20 | Pfizer-BioNTech | No |
| 4 | 2022-12-29 | Pfizer-BioNTech | No |
Free text
Release 12 — day 0, dose 4
Systemic reaction (other): Currently 12 weeks pregnant
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Pregnancy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release